ES440348A1 - Benzomorphanes derivatives - Google Patents

Benzomorphanes derivatives

Info

Publication number
ES440348A1
ES440348A1 ES440348A ES440348A ES440348A1 ES 440348 A1 ES440348 A1 ES 440348A1 ES 440348 A ES440348 A ES 440348A ES 440348 A ES440348 A ES 440348A ES 440348 A1 ES440348 A1 ES 440348A1
Authority
ES
Spain
Prior art keywords
methyl
formula
action
denotes hydrogen
morphine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES440348A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES440348A1 publication Critical patent/ES440348A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Novel 2-tetrahydrofurfuryl-6-7-benzomorphans of the accompanying formula I, in which R<1> denotes methyl, ethyl or propyl R<2> denotes hydrogen, methyl or ethyl R<3> denotes hydrogen or methyl and R<4> denotes hydrogen, alkyl having 1 to 4 carbon atoms or acyl having 2 to 5 carbon atoms, are prepared by introducing the tetrahydrofurfuryl radical into appropriately substituted norbenzomorphans by the methods of N-alkylation. The resulting bases of the formula I can then be converted into their acid addition salts. The compounds of the formula I and their acid addition salts are distinguished by a therapeutically utilisable action on the central nervous system. Particularly to be emphasised is their analgesic action, which frequently exceeds that of morphine, without exhibiting the undesired side effects of morphine, e.g. the addictive action.
ES440348A 1974-03-09 1975-08-20 Benzomorphanes derivatives Expired ES440348A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2411382A DE2411382C3 (en) 1974-03-09 1974-03-09 2-Tetrahydrofurfuryl-6,7-benzomorphane, process for the preparation and their use

Publications (1)

Publication Number Publication Date
ES440348A1 true ES440348A1 (en) 1977-06-01

Family

ID=5909593

Family Applications (6)

Application Number Title Priority Date Filing Date
ES440348A Expired ES440348A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives
ES440350A Expired ES440350A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives
ES440349A Expired ES440349A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives
ES440345A Expired ES440345A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives
ES440347A Expired ES440347A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives
ES440346A Expired ES440346A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives

Family Applications After (5)

Application Number Title Priority Date Filing Date
ES440350A Expired ES440350A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives
ES440349A Expired ES440349A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives
ES440345A Expired ES440345A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives
ES440347A Expired ES440347A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives
ES440346A Expired ES440346A1 (en) 1974-03-09 1975-08-20 Benzomorphanes derivatives

Country Status (25)

Country Link
JP (1) JPS5827275B2 (en)
AT (1) AT344332B (en)
BE (1) BE826440A (en)
BG (3) BG25087A3 (en)
CA (1) CA1049511A (en)
CH (8) CH612425A5 (en)
CS (1) CS188221B2 (en)
DD (1) DD119236A5 (en)
DE (1) DE2411382C3 (en)
DK (1) DK137188C (en)
ES (6) ES440348A1 (en)
FI (1) FI63571C (en)
FR (1) FR2262984B1 (en)
GB (1) GB1496418A (en)
HU (1) HU177408B (en)
IE (1) IE40945B1 (en)
IL (1) IL46760A (en)
NL (1) NL7502724A (en)
NO (1) NO141800C (en)
PH (1) PH14127A (en)
PL (3) PL93700B1 (en)
RO (2) RO69617A (en)
SE (1) SE421919B (en)
SU (3) SU577982A3 (en)
ZA (1) ZA751394B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716687A1 (en) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-HYDROXY-2- (5-ISOXAZOLYLMETHYL) -6.7BENZOMORPHANES, THEIR ACID ADDITIONAL SALTS AND MEDICINAL PRODUCTS CONTAINING THEM
DE2828039A1 (en) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2- (2-ALKOXYETHYL) -2'-HYDROXY-6,7-BENZOMORPHANES THEIR ACID ADDITION SALTS, THESE MEDICINAL PRODUCTS, AND METHOD FOR THE PRODUCTION THEREOF
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6492420B2 (en) 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
CA2215069C (en) * 1995-03-10 2006-09-12 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
JP5470557B2 (en) 2007-07-26 2014-04-16 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1
CL2008003407A1 (en) 2007-11-16 2010-01-11 Boehringer Ingelheim Int Substituted heterobicyclo aryl- and heteroarylcarbonyl derivative compounds; pharmaceutical composition; preparation procedure; and its use in the treatment and / or prevention of metabolic disorders, mediated by the inhibition of the enzyme hsd-1.
JP5490014B2 (en) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β-hydroxysteroid dehydrogenase type 1 cyclic urea inhibitor
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
CA2715290A1 (en) 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8138178B2 (en) 2008-05-01 2012-03-20 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8569292B2 (en) 2008-05-01 2013-10-29 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AR071719A1 (en) 2008-05-13 2010-07-07 Boehringer Ingelheim Int ALICICLIC DERIVATIVES OF CARBOXILIC ACID OF BENZOMORPHANS AND RELATED STRUCTURES, MEDICINES CONTAINING THESE COMPOUNDS AND THEIR USE. OBTAINING PROCESSES
NZ590495A (en) 2008-07-25 2012-10-26 Vitae Pharmaceuticals Inc Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
UY33001A (en) 2009-11-06 2011-05-31 Boehringer Ingelheim Int ARYL AND HETEROARILCARBONYL HIVAHYDROINDENOPIRIDINE AND OCTAHYDROBENZOQUINOLINE DERIVATIVES
US8933072B2 (en) 2010-06-16 2015-01-13 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (en) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
WO2013025664A1 (en) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Indenopyridine derivatives

Also Published As

Publication number Publication date
ES440349A1 (en) 1977-03-01
IL46760A0 (en) 1975-05-22
SU588916A3 (en) 1978-01-15
FI63571B (en) 1983-03-31
GB1496418A (en) 1977-12-30
PL93700B1 (en) 1977-06-30
BG24814A4 (en) 1978-05-12
CA1049511A (en) 1979-02-27
BE826440A (en) 1975-09-08
BG25087A3 (en) 1978-07-12
ZA751394B (en) 1976-11-24
SE421919B (en) 1982-02-08
CH620439A5 (en) 1980-11-28
FI750652A (en) 1975-09-10
AU7894275A (en) 1976-09-16
ES440345A1 (en) 1977-03-01
IE40945L (en) 1975-09-09
DK137188B (en) 1978-01-30
CH612425A5 (en) 1979-07-31
RO70051A (en) 1980-12-30
CH622016A5 (en) 1981-03-13
NO750773L (en) 1975-09-10
CS188221B2 (en) 1979-02-28
FR2262984A1 (en) 1975-10-03
NO141800B (en) 1980-02-04
ATA153875A (en) 1977-11-15
HU177408B (en) 1981-10-28
NO141800C (en) 1980-06-04
PL93699B1 (en) 1977-06-30
RO69617A (en) 1980-08-15
ES440346A1 (en) 1977-03-01
DK137188C (en) 1978-07-03
SU577982A3 (en) 1977-10-25
DD119236A5 (en) 1976-04-12
ES440347A1 (en) 1977-06-01
PL93499B1 (en) 1977-05-30
SU577983A3 (en) 1977-10-25
CH620681A5 (en) 1980-12-15
PH14127A (en) 1981-02-26
AT344332B (en) 1978-07-10
CH622015A5 (en) 1981-03-13
CH622014A5 (en) 1981-03-13
DK92975A (en) 1975-09-10
JPS50123675A (en) 1975-09-29
IE40945B1 (en) 1979-09-12
NL7502724A (en) 1975-09-11
CH622017A5 (en) 1981-03-13
IL46760A (en) 1978-12-17
DE2411382B2 (en) 1979-01-18
BG24813A4 (en) 1978-05-12
DE2411382A1 (en) 1975-09-18
JPS5827275B2 (en) 1983-06-08
CH620440A5 (en) 1980-11-28
DE2411382C3 (en) 1979-09-06
ES440350A1 (en) 1977-03-16
FI63571C (en) 1983-07-11
FR2262984B1 (en) 1978-07-28
SE7502592L (en) 1975-09-10

Similar Documents

Publication Publication Date Title
ES440345A1 (en) Benzomorphanes derivatives
PT83843A (en) Process for preparing prodrugs of rapamycin
ES431511A1 (en) 2-Heteroaryl-methyl)-5,9{62 -dialkyl-6,7-benzomorphans and salts thereof
ES382550A1 (en) 2-(aminoalkyl-amino)-4-amino thieno(3,2-d)pyrimidines
GB1023220A (en) Production of carboxylic acid amides
GB1062714A (en) -ß-(4&#39;-acyloxy-4&#39;-piperidyl)-ketones
ES449099A1 (en) 4-(9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thiophen-4-ylidene)piperidenes
GB1314952A (en) 3,4,5-trialkoxy-benzoic acid derivatives and their uses
ES317454A1 (en) Procedure for the preparation of amidas of derivatives of lysergic acid. (Machine-translation by Google Translate, not legally binding)
GB925723A (en) Novel thebaine derivatives
ES307982A1 (en) Procedure for the preparation of new amidas of ariloxyacetic acid. (Machine-translation by Google Translate, not legally binding)
ES484422A1 (en) Isomerisation of 3-azabicyclo(3.1.0)hexane derivatives.
ES474986A1 (en) Isoquinoline derivatives
ES274909A1 (en) Iminodibenzyl derivatives
ES403910A1 (en) Imidazo-4,5-b-pyridine derivatives
ES459866A1 (en) Indole derivatives and process for preparing the same
ES383107A1 (en) Procedure for the preparation of new derivatives of dibenzociclopropapenteen. (Machine-translation by Google Translate, not legally binding)
IE41788L (en) Phenylbutazone derivatives
ES450472A1 (en) Benzoyl pyrazole 5-acetic acid derivatives useful as uricosurucs
ES289117A1 (en) A procedure for the preparation of new derivatives of 6-methyl and 1,6-dimethyl-8-amino-methyl-ergoline i (Machine-translation by Google Translate, not legally binding)
ES373930A1 (en) Procedure for the preparation of new derivatives of azepine. (Machine-translation by Google Translate, not legally binding)
ES305125A1 (en) Procedure for the preparation of new derivatives of etanoantraceno. (Machine-translation by Google Translate, not legally binding)
ES305716A1 (en) Procedure for the production of alcaloids. (Machine-translation by Google Translate, not legally binding)
ES443610A1 (en) Procedure for preparing isoquinoline derivatives. (Machine-translation by Google Translate, not legally binding)
ES450876A1 (en) Pyrido (3,4-b)indole derivatives